About us
Tongcheng Medicine specializes in the research and development, production, and sales of fine chemical products.
Products
The company has currently developed and constructed a fine chemical product system with bromine and chlorine series as the core
News
Stay up-to-date with the latest news from Shandong Tongcheng Medicine Co., Ltd!
Honors
The company has been awarded various honors and invention patent certificates
About Us
Company Profile

        Shandong Tongcheng Medicine Co., Ltd. (hereafter be referred as “The company”) was established in January, 2009, with register capital of 81.9 million Yuan. It cover an area of 560mu. Located in Houzhen Chemical Industry Park, Shouguang, the company specializes in the research and development, production and sales of fine chemical products. Since its establishment, the company has focused on the research and development of fine chemical products. Up to now, relying on the abundant local resources of bromine, hydrobromic acid and hydrochloric acid, the company has developed and constructed a fine chemical product system with bromine series and chlorine series as the core, and achieved recyclable, economic and green production. The company has been awarded the honorary title of national high-tech enterprise, provincial hidden enterprise champion, provincial specialty and special new, municipal enterprise technology center, etc. The company was listed in the National SME share transfer system on June 13, 2016, stock abbreviation: Tongcheng Medicine, stock code: 837062.

        The company's products are widely used in phenolic foam insulation board materials, pharmaceutical apis and intermediates, pesticide apis and intermediates, dyes and intermediates, flavors, active agents, flame retardants, chemical additives and other application fields.  With excellent product quality, product cost and scale advantages, the company has achieved a relatively stable customer base, It has established good and stable cooperative relations with well-known customers at home and abroad such as LG HAUSYS of Korea, Beixing Chemical of Japan (terminal customer), Givudan, FMC of the United States, LIVENT CORPORATION, Kingspang of the United Kingdom (terminal customer), Xiangzhong Pharmaceutical, Zhongqi Shares, Ganfeng Lithium, Sunda Biology, etc. The company has a strong customer advantage.

  • 2009

    The company was founded in 2009

  • 560

    The company covers an area of 560 mu

  • 400

    The company has nearly 400 employees

  • 12

    The company has obtained 12 invention patents